N/A
N=10
Measurement of Kidney Blood Flow and Oxygen Levels by MRI
Chronic Kidney Disease
Bottom Line
View on ClinicalTrials.gov: NCT01318967 ↗Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Apr 2015
Primary outcome: Primary: Measurement of Renal Blood Flow of the Kidney by the PAH Method — 190 ml/min
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Furosemide (Drug); Placebo (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Wake Forest University
- Primary completion
- Jun 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Measurement of Renal Blood Flow of the Kidney by the PAH Method |
190 | — |
| SECONDARY Measurement of Regional Blood Oxygenation by MRI |
300 | — |
Summary
Comparison of renal blood flow measurements by PAH clearance and MRI
Eligibility Criteria
Inclusion Criteria
In this study, the investigators will enroll 16 men and women aged ≥ 18 years with Stage II - V chronic kidney disease (CKD). In addition, the investigators will enroll 4 subjects with a glomerular filtration rate (GFR) of greater than 60 ml/min who do not have any evidence of CKD.
Exclusion Criteria
This study excludes those not suitable for MRI or for the interventional pharmacologic procedures.
Data sourced from ClinicalTrials.gov (NCT01318967). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.